Search
Now showing items 1-10 of 11
Methoxetamine-related deaths in the UK : an overview
(2015-07-28)
Objective: The goal of this study is to provide an update on the data given on methoxetamine (MXE)-related fatalities that occurred in 2011–2013, presented at the Second International Conference on Novel Psychoactive ...
Deaths of individuals aged 16-24 years in the UK after using mephedrone
(2015-07-28)
Objective: Mephedrone is a stimulant drug chemically related to amphetamine, with effects similar to those of amphetamine and cocaine. This study aims to analyse fatalities following ingestion of mephedrone in the UK amongst ...
Profiling online recreational/prescription drugs' customers and overview of drug vending virtual marketplaces
(2015-07-28)
OBJECTIVES: Internet and social networking sites play a significant role in the marketing and distribution of recreational/prescription drugs without restrictions. We aimed here at reviewing data relating to the profile ...
Venlafaxine as the ‘baby ecstasy’? : Literature overview and analysis of web-based misusers’ experiences
(2015-07-28)
Introduction :Venlafaxine is one of the most frequently prescribed antidepressants worldwide, despite its toxicity risk in overdose. Furthermore, the molecule has been recently identified at the EU-wide level as one of the ...
Olanzapine as the ideal ‘trip terminator’? : Analysis of online reports relating to antipsychotics’s use and misuse following occurance of novel psychoactive substance-related psychotic symptoms
(2015-07)
The pharmacological self-management of novel psychoactive substance (NPS)-induced psychopathological consequences represents a fast growing phenomenon. This is facilitated by the frequent sharing of NPS intake experiences ...
Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4 butanediol (1,4-BD; BDO) : a literature review with a focus on UK fatalities related to non-medical use
(2015-06)
Misuse of gamma hydroxybutrate (GHB) and gamma butyrolactone (GBL) has increased greatly since the early 1990s, being implicated in a rising number of deaths. This paper reviews knowledge on GHB and derivatives, and explores ...
Survey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacists
(2015-06-01)
Purpose: To determine pharmacists’ knowledge of legal highs (novel psychoactive substances; NPS). Approach: A questionnaire was handed out at 2 London pharmacist continuing education events in mid-2014. These events update ...
Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe (2008-2012)
(2015-05-29)
The present study aimed at systematically reviewing the role and extent of patient-reported outcomes (PROs) usage within the package of scientific evidence considered for marketing authorization (MA). All regulatory ...
Mind Navigators of Chemicals' Experimenters? A Web-Based Description of E-Psychonauts
(2015-05-12)
Within online drug fora communities, there are some "educated and informed" users who can somehow provide reliable information on psychoactive compounds and combinations. These users, also called "e-psychonauts," may possess ...
Novel psychoactive substances of interest for psychiatry
(2015-02)
Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine-like dissociatives, piperazines, ...